- >=99.0 HPLCHPLC / MSIn stock
Research compound
GLP-1(S)
GLP-1(S) (Semaglutide) is a synthetic GLP-1 receptor agonist with 94% sequence homology to native GLP-1 7-36 amide. Structural modifications are specified as: C18 fatty di-acid conjugation at Lys26 enabling reversible albumin binding, and an Aib substitution at position 8 conferring DPP-IV resistance. These modifications extend plasma half-life in pharmacokinetic models relative to the native sequence. It is the characterization standard for long-acting GLP-1R agonism, receptor internalization kinetics, and beta-cell cAMP signaling assays. For laboratory research use only.
Specification
- CAS
- 910463-68-2
- Molecular weight
- 4113.58 g/mol
- Formula
- C187H291N45O59
- Purity
- >=99.0 HPLC
- Storage
- -20 °C, lyophilized
Size
Research notes
What is GLP-1(S)?
GLP-1(S) is a synthetic research compound studied in laboratory settings. It has molecular formula C187H291N45O59, a molecular weight of 4113.58 g/mol, CAS 910463-68-2. It is intended for in vitro research use only and is not for human or animal use.
What purity is Valitec Peptides's GLP-1(S)?
Valitec Peptides supplies GLP-1(S) at >=99.0% purity, verified by third-party HPLC analysis. A certificate of analysis is available on request.
How is GLP-1(S) supplied?
GLP-1(S) is supplied as a lyophilized powder in sealed research-grade vials, stored -20 °C, lyophilized, intended for in vitro and laboratory research use only.
For laboratory research use only. Not for human or veterinary use, and not for diagnostic or therapeutic use.